Baird Medical Investment Holdings Limited revenue by segment BDMDW
Baird Medical Investment Holdings Limited splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Microwave Ablation Needles at $17.2 million, 76% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
|---|---|---|
| Revenue |
23
|
37
|
| Microwave Ablation Needles |
17
-49.1%
share 76.4%
|
34
share 91.3%
|
| Microwave Ablation Therapeutic Apparatus |
5
+66.3%
share 23.6%
|
3
share 8.6%
|
| Other Medical Devices |
—
|
0
share 0.0%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDMD (Nasdaq), BDMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Sheung Wan
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1982444
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.